INS and Hypoglycemia: In contrast, insulin release from an unregulated subcutaneous depot in type 1 diabetes and/or the continued action of sulfonylureas in a non-glucose dependent manner in type 2 diabetes means that systemic insulin levels remain relatively high during hypoglycaemia in diabetes.